ReviewTherapeutic advances in medical oncology2020

Targeting RON receptor tyrosine kinase for treatment of advanced solid cancers: antibody-drug conjugates as lead drug candidates for clinical trials.

Hang-Ping Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.